Evolve Private Wealth’s Xylem XYL Stock Holding History

Evolve Private Wealth’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,727	Closed	-$206K	–	1257
2026 Q1	$206K	Sell	1,727 -239	-12%	-$31.3K	0.01%	925
2025 Q4	$268K	Buy	+1,966	New	+$283K	0.02%	775

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Evolve Private Wealth's XYL Position: Q2 2026 in Review

Evolve Private Wealth sold out of Xylem (XYL) in Q2 2026, closing a stake of 1,727 shares — an estimated $206K sold.

Evolve Private Wealth first reported a position in XYL in Q4 2025 and held it in 2 quarters. The position peaked at $268K in Q4 2025. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Evolve Private Wealth reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
Evolve Private Wealth sold 1,727 Xylem shares in Q2 2026, an estimated $206K.
Evolve Private Wealth first reported a position in Xylem in Q4 2025 and held it in 2 quarters.
Evolve Private Wealth's Xylem position peaked at $268K in Q4 2025.
1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.